New Medical Device Company Excimer Therapies Debuts at 2018 American Academy of Dermatology Annual Meeting and Inks Exclusive Agreement for U.S. Distribution Rights to the exciplex® Treatment System

Excimer Therapies Inc. is the exclusive USA distributor of the FDA Approved exciplex® UVB phototherapy system, for the treatment of psoriasis, vitiligo, atopic dermatitis (eczema) and leukoderma.SAN DIEGO, Feb. 15, 2018 /PRNewswire/ — Excimer Therapies Inc., a medical device company focused on the treatment of certain conditions that are amenable to phototherapy treatment, has been awarded exclusive U.S. distribution rights for the Clarteis SAS exciplex®, the lightest and most…


Source: https://www.prnewswire.com/news-releases/new-medical-device-company-excimer-therapies-debuts-at-2018-american-academy-of-dermatology-annual-meeting-and-inks-exclusive-agreement-for-us-distribution-rights-to-the-exciplex-treatment-system-300599236.html

About the Author

has written 41525 stories on this site.

Copyright © 2010 Business and Corporate News.